Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

GAMZE VARAN

Doktor Öğretim Üyesi

Hacettepe Üniversitesi Aşı Enstitüsü Aşı Teknolojisi Anabilim Dalı

Research topics OpenAlex
Articles 28 YÖKSİS 28 · OpenAlex 0 Total citations 688 h-index 13 · OpenAlex Q1 articles 14 Scopus · WoS Q1 11 Best field rank #9 / 39 Side field · top 23.1% Co-authors 48 11 Turkish institutions
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Farmasotik Biyoteknoloji
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 28
YÖKSİS28 OpenAlex0
Projects 10
Books 8
Proceedings 35

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 27 + YÖKSİS · co-author record: 3
h-index 13 Percentile in Türkiye: 90 #498 of 2,360 at their university by h-index
i10-index
15
Total citations
688
Top 9.4% in Türkiye
Per article
22.9
FWCI
1.63
1.00 = world average
World top 1%
1
World top 10%
3

Most cited articles

  1. Amphiphilic cyclodextrin nanoparticles 2017 world top 10% 156 citations
  2. Identification of unknown bodies by using CT images of frontal sinus 2007 103 citations
  3. A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers 2021 world top 10% 103 citations

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 3 articles (112 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
48
With an akaturk profile
32
Turkish institutions
11
Co-authored works
%96

Academic co-authors 32

  1. EREM BİLENSOY Profesör · Hacettepe Üniversitesi same university 19
  2. NAZLI ERDOĞDU Doçent · Hacettepe Üniversitesi same university 5
  3. AYŞE ERCAN Profesör · Hacettepe Üniversitesi same university 4
  4. CEM VARAN Doktor Öğretim Üyesi · Hacettepe Üniversitesi same university 4
  5. GÜNEŞ ESENDAĞLI Profesör · Hacettepe Üniversitesi same university 4
  6. SEMRA SOYDAM Doçent · Hacettepe Üniversitesi same university 4
  7. MUSTAFA ÇELEBİER Profesör · Hacettepe Üniversitesi same university 3
  8. DİLARA ÖRGÜL Doktor Öğretim Üyesi · Selçuk Üniversitesi 2
  9. OZAN KAPLAN Araştırma Görevlisi · Hacettepe Üniversitesi same university 2
  10. SÜLEYMAN CAN ÖZTÜRK Doktor Öğretim Üyesi · Hacettepe Üniversitesi same university 2
Show all (32)
  1. ABDURRAHMAN OLĞAÇ Doktor Öğretim Üyesi · Gazi Üniversitesi 1
  2. ARİF AHMET BAŞARAN Profesör · Başkent Üniversitesi 1
  3. AYKUT ÖZKUL Profesör · Ankara Üniversitesi 1
  4. BUSE TÜREGÜN ATASOY Doktor Öğretim Üyesi · Hacettepe Üniversitesi same university 1
  5. DAVUT AKSÜT Doçent · Hacettepe Üniversitesi same university 1
  6. DUYGU ENEŞ Araştırma Görevlisi · Başkent Üniversitesi 1
  7. ECE ÇOBANOĞLU Araştırma Görevlisi · Mersin Üniversitesi 1
  8. ELİF KARAKOÇ Doktor Öğretim Üyesi · Hacettepe Üniversitesi same university 1
  9. ENGİN KOÇAK Doçent · Sağlık Bilimleri Üniversitesi 1
  10. JÜLİDE SECERLİ Araştırma Görevlisi · Sağlık Bilimleri Üniversitesi 1
  11. MERVE GÜDÜL BACANLI Profesör · Sağlık Bilimleri Üniversitesi 1
  12. MERVE NENNİ Doktor Öğretim Üyesi · Çukurova Üniversitesi 1
  13. MURAT ŞEN Profesör · Hacettepe Üniversitesi same university 1
  14. MİNE DURUSU TANRIÖVER Profesör · Hacettepe Üniversitesi same university 1
  15. NERGİZ YILMAZ Profesör · İzmir Katip Çelebi Üniversitesi 1
  16. PETEK KORKUSUZ Profesör · Hacettepe Üniversitesi same university 1
  17. SADIK KAĞA Doçent · Afyon Kocatepe Üniversitesi 1
  18. SEDAT ÜNAL Doçent · Erciyes Üniversitesi 1
  19. SEVAL OLĞAÇ Araştırma Görevlisi · Gazi Üniversitesi 1
  20. SIDIKA ÖZTOP Doktor Öğretim Üyesi · Ankara Medipol Üniversitesi 1
  21. YEŞİM AKTAŞ Profesör · Erciyes Üniversitesi 1
  22. ZEYNEP ŞAFAK TEKSİN Profesör · Gazi Üniversitesi 1

National collaboration 11 institutions

Within own university25 joint works · Hacettepe Üniversitesi

  1. Sağlık Bilimleri Üniversitesi 2 works · 3 academics
  2. Selçuk Üniversitesi 2 works · 1 academics
  3. Afyon Kocatepe Üniversitesi 1 works · 1 academics
  4. Ankara Medipol Üniversitesi 1 works · 1 academics
  5. Ankara Üniversitesi 1 works · 1 academics
  6. Başkent Üniversitesi 1 works · 2 academics
  7. Erciyes Üniversitesi 1 works · 2 academics
  8. Gazi Üniversitesi 1 works · 3 academics
  9. Mersin Üniversitesi 1 works · 1 academics
  10. Çukurova Üniversitesi 1 works · 1 academics
Show all (11)
  1. İzmir Katip Çelebi Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 16

Juan M. Benito 7SAFİYE AKKIN 5Milo Malanga 4NURBANU DEMİRTÜRK 3SELİN ÖNCÜL 3SERHAT ÜNAL 3Sibel Gökşen 3Carmen Ortiz Mellet 2ANIL IŞIKATİLLA HINCALAtieh RezvankhahBerat ÜrgüplüGerrit BorchardTarık FedaiViorica PatruleaZİYNETİ EKE

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Index quartiles

?
Scopus (SJR) 22
  • Q1 14 %63.6
  • Q2 5 %22.7
  • Q3 3 %13.6
  • Q4 0 %0.0
WoS (JCR) 25
  • Q1 11 %44.0
  • Q2 8 %32.0
  • Q3 2 %8.0
  • Q4 4 %16.0
TR Index 3 articles
OpenAlex citation percentile
Top 1%1
Top 10%3
Avg · n 27 %60.6
Other counts

Scopus (SJR)

  • YÖKSİS rows 22

WoS (JCR)

  • YÖKSİS rows 25

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

28articles

Journals with publications

21 journals

Narrow down

Scopus (SJR)
Q114 Q25 Q33 Q40
WoS (JCR)
Q111 Q28 Q32 Q44
TR Index
3articles

Article list

  1. 2026 Screening Oil Components for Interleukin-2-Loaded Lipid-Based Formulations with Molecular Dynamics, In Vitro Characterization, and Cell Culture Evaluation ACS Omega DOI 10.1021/acsomega.5c12065 YÖKSİS SJR Q1 JCR Q2 OpenAlex 11.6%
  2. 2026 CD44-targeted cyclodextrin-hyaluronic acid nanoparticles carrying gemcitabine and paclitaxel to pancreatic cancer European Journal of Pharmaceutical Sciences DOI 10.1016/j.ejps.2026.107527 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.4%
  3. 2026 Development of Film Formulations of Acyclovir as Safe and Effective Antiviral Agent: Optimization, In Vitro Characterization and Antialphaherpesviral Efficacy Journal of Pharmaceutical Innovation DOI 10.1007/s12247-026-10598-8 YÖKSİS SJR Q3 JCR Q3 OpenAlex 21.6%
  4. 2026 Paclitaxel loaded human serum albumin nanoparticles, from batch to microfluidics: A smart manufacturing approach for nab-paclitaxel nanosimilar candidate and in vitro head-to-head comparison Journal of Drug Delivery Science and Technology DOI 10.1016/j.jddst.2025.107687 YÖKSİS SJR Q2 JCR Q1 OpenAlex 78.1%
  5. 2026 A PROMISING LIPOSOMAL VACCINE CANDIDATE AGAINST EPSTEIN-BARR VIRUS: AN IN VITRO EVALUATION Ankara Universitesi Eczacilik Fakultesi Dergisi DOI 10.33483/jfpau.1818424 YÖKSİS SJR Q3 OpenAlex 0.3%
  6. 2025 Therapeutic potential of Momordica charantia L. Extracts on melanoma cells revealed by metabolomic profiling BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES DOI 10.1590/s2175-97902025e24283 YÖKSİS SJR Q3 JCR Q4 OpenAlex 52.2%
  7. 2025 DENGUE VIRUS: EPIDEMIOLOGY, BIOLOGY AND CHALLENGES OF VACCINE DEVELOPMENT Journal of One Health Research DOI 10.5281/zenodo.14932860 YÖKSİS
  8. 2024 Folate Receptor β (FRβ) Expression on Myeloid Cells and the Impact of Reticuloendothelial System on Folate-Functionalized Nanoparticles’ Biodistribution in Cancer Molecular Pharmaceutics DOI 10.1021/acs.molpharmaceut.4c00663 YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.4%
  9. 2024 In vitro and ex vivo evaluation of chitosan gel containing metformin-loaded polymeric nanoparticles for topical treatment of melanoma DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY DOI 10.1080/03639045.2024.2372290 YÖKSİS SJR Q2 JCR Q3 OpenAlex 59.8%
  10. 2024 Optimization and characterization of Rituximab targeted multidrug loaded cyclodextrin nanoparticles against Non-Hodgkin Lymphoma International Journal of Pharmaceutics DOI 10.1016/j.ijpharm.2024.124488 YÖKSİS SJR Q1 JCR Q1 OpenAlex 52.8%
  11. 2024 İnfluenza/B Yamagata Suşu ve İnfluenza Aşıları Flora the Journal of Infectious Diseases and Clinical Microbiology DOI 10.5578/flora.2024021036 YÖKSİS TR Index JCR Q4 OpenAlex 56.7%
  12. 2023 Insight into oral amphiphilic cyclodextrin nanoparticles for colorectal cancer: comprehensive mathematical model of drug release kinetic studies and antitumoral efficacy in 3D spheroid colon tumors. Beilstein Journal of Organic Chemistry DOI 10.3762/bjoc.19.14 YÖKSİS SJR Q2 JCR Q2 OpenAlex 78.4%
  13. 2023 Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer Pharmaceutics DOI 10.3390/pharmaceutics15020314 YÖKSİS SJR Q1 JCR Q1 OpenAlex 67.8%
  14. 2023 Cyclodextrin in Vaccines: Enhancing Efficacy and Stability Future Pharmacology DOI 10.3390/futurepharmacol3030038 YÖKSİS JCR Q2 OpenAlex 66.6%
  15. 2022 A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU Elsevier BV DOI 10.1016/j.ijpharm.2022.121940 YÖKSİS SJR Q1 JCR Q1 OpenAlex 76.5%
  16. 2022 Peptide Based Vaccine Strategies Bilimsel Tip Publishing House DOI 10.5578/flora.20229801 YÖKSİS TR Index JCR Q4 OpenAlex 7.6%
  17. 2022 COVID-19 Aşı Geliştirme Çalışmaları ve Nanoteknoloji Yaklaşımları Bilimsel Tip Publishing House DOI 10.5578/flora.20229601 YÖKSİS TR Index JCR Q4 OpenAlex 9.6%
  18. 2021 Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver Journal of Drug Targeting DOI 10.1080/1061186X.2020.1853743 YÖKSİS OpenAlex 83.0%
  19. 2021 Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level International Journal of Pharmaceutics DOI 10.1016/j.ijpharm.2021.120379 YÖKSİS SJR Q1 JCR Q1 OpenAlex 57.6%
  20. 2021 Erlotinib complexation with randomly methylated β-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY DOI 10.1080/10837450.2021.1946695 YÖKSİS SJR Q2 JCR Q2 OpenAlex 46.1%

← Back to academicians